| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.7 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |